CHE CHEMED CORP
2026Q1 · CUSIP 16359R103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
485
Δ holders QoQ
-28
Breadth percentile
Top 95%
Whale holders
215
Δ whales
-2
Inst. holding value
$4.8B
New positions
55
Closed positions
83
Price momentum (1Q)
-6.5%
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q1 | Top 8% | -21.3% | -24.9% |
| 2023Q4 | Top 10% | -3.0% | -0.8% |
| 2023Q1 | Top 9% | -6.9% | +7.1% |
| 2022Q4 | Top 16% | +4.0% | -2.2% |
| 2020Q3 | Top 12% | +2.9% | +2.7% |
| 2019Q3 | Top 4% | +17.6% | +14.4% |
| 2019Q1 | Top 12% | +29.8% | +24.8% |
| 2018Q3 | Top 14% | +1.4% | +7.2% |
| 2018Q2 | Top 3% | -3.0% | -0.5% |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
4
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
28.0
EPS (TTM)
$18.32
EPS YoY
-10.7%
Revenue (TTM)
$2.5B
Revenue YoY
+2.1%
Net margin
10.2%
ROE
30.6%
Debt ratio
44.8%
FCF (TTM)
$377M
Dividend (TTM)
$2.30
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.